yield10.png
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
29 févr. 2024 08h31 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported that its proprietary...
2024.02_Yield10_VISION_LicenseAgreement_HT-Camelina_Biofuel
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
14 févr. 2024 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass. and LONGMONT, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, and VISION Bioenergy...
yield10.png
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
07 févr. 2024 17h40 HE | Yield10 Bioscience, Inc.
-Prioritizes Activities to Advance Omega-3 Camelina Program in 2024 -Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chile - Company also Provides Update on Nasdaq Status...
yield10.png
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
08 janv. 2024 08h31 HE | Yield10 Bioscience, Inc.
Yield10 Bioscience files RSR with USDA-APHIS for elite Camelina designed to produce EPA/DHA omega-3 oils
yield10.png
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
15 nov. 2023 08h32 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the U.S. Department of...
yield10.png
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
15 nov. 2023 08h31 HE | Yield10 Bioscience, Inc.
-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils -On Track for Commercial Launch of Glufosinate Tolerant...
yield10.png
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
14 nov. 2023 16h01 HE | Yield10 Bioscience, Inc.
-Establishes "Camelina Seed Genetics to Biofuel" Platform-Advances Herbicide Tolerant Camelina Varieties toward Commercialization-Exercises Option to Finalize Exclusive, Global Commercial License to...
yield10.png
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
08 nov. 2023 08h31 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report...
yield10.png
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land
31 oct. 2023 08h31 HE | Yield10 Bioscience, Inc.; BioMar Group
Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA equal to fish oil. After a decade of...
yield10.png
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
18 oct. 2023 08h31 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has...